Replies to post #113644 on Biotech Values

[vinmantoo]

For all the press BRCA1/2 gets, it is prominent in familial breast cancer, not in sporadic breast cancer. Off hand, I recall that the BRCA1/2 breast cancers represent under 10% of the total and may be as low as 5%.

[ghmm]

AZN's PARP in Ovarian cancer seem encouraging so maybe hope yet for PARP's

http://finance.yahoo.com/news/Phase-II-Study-Results-bw-2670419048.html?x=0&.v=1